Coach, I think you are right with the AXSM comparison at least on a relative basis. I am expecting a slower increase than what others are predicting here. Not because the stock would not be worth it, but because it is a 2b and not a P3 trial and it will take a while for time lines to become clear. A lot of investors of AD stocks have been burnt making big bets on P2 results, so unless there is a BP partnership I think it goes up slower than it should.
Market Data 
Markets 
AI
